Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 06, 2023
Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis.
Journal: The Journal of clinical investigation
Published: January 21, 2020
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 27, 2019
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.
Journal: The Journal of infectious diseases
Published: August 31, 2015
Showing 1-6 of 6
Last Updated: 09/26/2026